which occurs when there is essentially an overload of histamine in the body (more than we can break down). Increased histamine in the brain inhibits the release of serotonin, which can affect our mood and lead to depression, anxiety,
New report examines medication trends for depression, anxiety and insomniaAs COVID‐19 continues to significantly impact the United States from a physical, mental and financial standpoint, an early analysis by a pharmacy benefit management organization of filled prescriptions at the onset of COVID‐19...
Real-world trends of glucagon-like peptide-1 (GLP-1) receptor agonist and PAP therapy use show patients who were adherent to their GLP-1 medication had higher levels of PAP therapy use than those who were non-adherent to their GLP-1 medication SAN DIEGO, May 23, 2024 (GLOBE NEWSWIRE) -...
A chronic brain disorder that is characterized by partial or generalized spontaneous (unprovoked) recurrent epileptic seizures and, often, comorbidities such as anxiety and depression. Epileptogenesis The gradual process by which normal brain tissue becomes epileptic, encompassing the events in the latent...
The medication represents a pioneering class of antidepressants that selectively target 5HT1A receptors, thereby displaying a more favorable adverse effects profile. Anticipated to arrive in pharmacies early in 2024, gepirone offers a promising option for those seeking relief from depression without the ...
Sep 16, 2024 Bill Squires In the hustle and bustle of modern life, maintaining mental wellness is crucial. Essential oils, known for their aromatic and therapeutic properties, can play a supportive role in managing anxiety, stress, and depression. These natural extracts from plants can help cre...
2025 2024 January January 2, 2025 Original Investigation Transcriptomic Profiles in Nasal Epithelium and Asthma Endotypes in Youth Molin Yue, MS; Kristina Gaietto, MD, MPH; Yueh Ying Han, PhD; et al. Abstract Full Text has audio JAMA. Published online January 2, 2025. doi:10.1001/ja...
Patients with scores ≥4 on the Screener and Opioid Assessment for Patients with Pain-Short Form were more likely to be younger than 55 years, have a higher morphine-equivalent daily dose, and report more feelings of pain, depression, and anxiety.6 The CDC’s Response At the University of ...
An investigational medication designated TAS-303 shows efficacy and safety in treatment of women with stress urinary incontinence (SUI), reports a placebo-controlled clinical trial in the August issue of The Journal of Urology.
The New Nordic Renal Diet (NNRD) is a whole-food approach, tailored to meet recommended guidelines in patients with moderate chronic kidney disease (stage 3b–4). The NNRD improved various metabolic and physiological endpoints during a 26-week randomized